Zum Inhalt springen
youtubeVideo laden:

Own a Piece of the Future of Home Skincare

As one of 100,000+ NIRA customers, you’ve been selected for an exclusive opportunity to invest in NIRA, limited to the first 48 individuals. Join us by backing our FDA-cleared, clinically proven system that is redefining at-home skincare technology.

We’re building a differentiated skincare platform driven by:

  • Fast growing home medical market
  • Low-cost, scalable DTC business model
  • New product launches planned each year
  • 17 core technology patents in 8 countries

We are projecting 6x revenue growth by 2029 and a targeted liquidity event in 2-5 years.

Minimum investment of $25,000.

Step 1 - View Investor Presentation Step 2 - See Prospectus & Invest

This investment if for people who meet the SEC requirement as an accredited investor.  Generally, this is someone who has a net worth over $1 million (excluding primary residence) or annual income over $200,000.  

Press logo 2.png
Press logo 3.png

Brand Highlights

100,000+ Customers
$45M+ Total Direct Sales
300+ Influencer Partners
NIRA Pro Laser - NIRA

A New Era in Skincare

Founded by laser expert David Bean, NIRA brings professional-grade skincare out of the dermatologist’s office and into the home. Built on decades of experience developing laser technology for medical use, NIRA introduced the first painless at-home laser for clinically proven wrinkle reduction—without downtime. Its non-fractional technology is backed by 17 international patents and devices are made in the USA.

Today, NIRA’s FDA-cleared technology is clinically proven to stimulate collagen and reduce wrinkles, earning thousands of five-star reviews, press recognition, and trust from skincare professionals.

As NIRA grows, it continues expanding its at-home solutions while staying focused on one goal: making effective, science-backed skincare simple and accessible.

Step 1 - View Investor Presentation Step 2 - See Prospectus & Invest
Made in the USA
FDA Cleared
Clinically Proven
Peer-Reviewed Clinical Studies

A Proven, Scalable Business Model

First FDA-cleared at-home laser, clinically proven to reduce the appearence of wrinkles.
Over 100k devices sold D2C at 70%+ gross margin
Core platform technology protected by 17 patents in 8 countries
Forecasting $40M in yearly revenue by 2028 with $6M net profits
Multi-market product roadmap with scalable operations based in the USA
In late-stage partnership discussions with leading market players

Press

Forbes

"The first at-home laser clinically proven to reduce wrinkles"

Marie Claire

"This at-home laser helped my skin glow more than any in-office treatment"

Yahoo! Life

"I'd go so far as to say that it's my favorite at-home device ever."

NewBeauty

"I highly recommend NIRA Pro to anyone looking for a painless, effective, and convenient solution to combat the signs of aging and achieve radiant, youthful skin at home."

Backed By Dermatologists

Dermatologist holding the NIRA Pro wrinkle reduction laser.

"If you use NIRA regularly, over time you will benefit from even more cumulative energy compared to an in-office treatment, and that can mean even better results."

Dr. Hadley King, MD
Board Certified Dermatologist

NIRA

“NIRA is quite extraordinary. It's now possible to achieve great results at home without any pain or irritation, and for a fraction of the cost of in-office treatments.”

Dr. Davin Lim
Board Certified Dermatologist / Laser Specialist

NIRA

Beyond Wrinkle Reduction

NIRA pioneered painless, at-home laser technology for skin renewal and wrinkle reduction—but we’re just getting started. We’re expanding our platform into new, high-demand categories, including:

  • Laser Hair Removal
  • Acne Treatment
  • Other Skin Diseases

Each of these new cateogories will strengthen our core platform—driving customer acquisition, increasing lifetime value, and positioning NIRA as a leader in at-home, science-backed skincare.

Step 1 - View Investor Presentation Step 2 - See Prospectus & Invest
NIRA

We're Scaling Fast

We’re setting a new standard in at-home skincare, with projected revenue compounding at 40%+ annually.

As revenue scales, profitability accelerates. Our margins are projected to expand alongside growth, with net income expected to increase by over $9M by the year 2029.

This means you’re investing in a skincare technology company built to scale efficiently and generate meaningful, long-term value.

Step 1 - View Investor Presentation Step 2 - See Prospectus & Invest